GMEP Medical Enters Exclusive Partnership in Nigeria

GMEP Medical has entered into an exclusive partnership in Nigeria, marking a significant step in expanding access to high-quality, innovative pharmaceuticals across Nigeria and West Africa. This strategic collaboration aims to drive meaningful impact and improve healthcare outcomes throughout the region.

Düsseldorf, Germany – June 2025 – GMEP Medical is pleased to announce the signing of an exclusive partnership agreement in Nigeria, marking a significant step forward in the company’s mission to broaden global access to high-quality and innovative pharmaceutical solutions.

This strategic collaboration represents a key milestone in GMEP Medical’s expansion across West Africa, enabling the introduction and distribution of its advanced therapeutic portfolio in one of the region’s most dynamic and rapidly growing healthcare markets.

The partnership aims to deliver proven, patient-centric treatments in areas of high unmet medical need, while also supporting the Nigerian healthcare system with sustainable, accessible solutions. Under this agreement, GMEP Medical and its Nigerian partner will work closely to register, promote, and distribute AmbroSpray® in the region.

“We are excited to partner with a trusted local organization that shares our commitment to innovation, compliance, and patient well-being,” said Asif Khan, Manager of International Business Development at GMEP Medical. “This partnership will allow us to bring impactful therapies to patients in Nigeria and set the stage for broader regional collaboration.”

GMEP Medical continues to strengthen its presence in Africa and other emerging markets through a network of trusted regional partners. The company remains focused on combining German quality with global accessibility to ensure that essential medicines reach the communities that need them most.